ArticlesHead-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis
Introduction
In 2004, a rapid HIV-antibody-based point-of-care test (Oraquick advance rapid HIV-1/2, OraSure Technologies Inc, PA, USA), initially approved for finger-stick, whole-blood, and plasma specimens, was approved by the US Food and Drug Administration (FDA) as a Clinical Laboratory Improvement Amendments waived test for use with specimens of oral mucosal transudate. Since 2006, with the widespread expansion of HIV testing in the USA, and with the possible expansion of home-based and new supervised self-testing initiatives in sub-Saharan Africa, this HIV test has become one of the most popular point-of-care tests based on oral specimens.1, 2, 3 It is more acceptable to patients because of its non-invasive and pain-free specimen collection and its rapid turnaround time.4, 5, 6 In Kenya and Uganda, an increased acceptance and preference for this test has helped improve the uptake of home-based HIV-testing initiatives.7, 8 The Kenyan Government also announced an expansion of bold and controversial self-testing initiatives for HIV, and is reviewing the possible approval of oral tests. Self-testing initiatives are also relevant for southern Africa, a region that has remained the epidemiological locus of the epidemic; countries such as Botswana, Lesotho, Mozambique, South Africa, Swaziland, Zambia, and Zimbabwe are focused on scaling up alternative HIV-screening programmes.
Oraquick is also being considered for potential use as an over-the-counter test in the USA and in many sub-Saharan countries. This move might revolutionise HIV testing by offering a proactive testing option to people who, because of stigma, do not wish to attend public health centres for testing. Hopefully, offering a confidential testing option will bring an end to the stigmatisation associated with HIV testing.9 Although performance data are available on this test from the USA, there has not been a review of its worldwide accuracy. With optimistic developments in HIV aimed at eradicating infection, worldwide expansion of HIV-testing programmes has taken centre stage because testing is the cornerstone of care and treatment.10 With self-testing initiatives imminent, programme planners and policy makers are keen to know the relative accuracy and performance of Oraquick in oral versus blood specimens, to decide on the optimum testing algorithm.
So far, worldwide comparative data on this test have not been critically synthesised and the effect of prevalence on test accuracy has not been reviewed. This exploration is important because countries with low prevalence for HIV might consider the possible expansion of HIV-screening initiatives in the future. With a view to generating the evidence base for policy recommendations, we aimed to review worldwide evidence of this popular point-of-care test.
Section snippets
Search strategy and selection criteria
In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines11 we undertook a systematic review and meta-analysis to compare the diagnostic accuracy of a rapid HIV-antibody-based point-of-care test (Oraquick advance rapid HIV-1/2) when used with oral versus blood-based specimens in adults. We searched the Cumulative Index to Nursing and Allied Health Literature, Medline, Embase, BIOSIS, and Web of Science between Jan 1, 2000, and June 1, 2011. We also
Results
Figure 1 shows the study selection. In our assessment of diagnostic accuracy, our pooled analyses showed seven studies in our first subgroup (studies reporting head-to-head comparisons of accuracy with specimens of oral mucosal transudate and whole blood) contributed ten data points, six studies in our second subgroup (specimens of oral mucosal transudate alone) contributed six data points, and 11 studies in our third subgroup (specimens of whole blood alone) contributed 17 data points. Figure 2
Discussion
In our first subgroup, which included studies with head-to-head comparisons of oral mucosal transudate and finger-stick specimens, the pooled sensitivity of the test in oral specimens was lower than the test's sensitivity in finger-stick specimens, a difference of about 2%. However, the specificity estimates were similar for both specimens. We give greater prominence to this comparison because within-study comparisons reduce confounding present in other subgroups because of different specimens,
References (44)
- et al.
Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection
J Clin Virol
(2010) - et al.
The diagnostic odds ratio: a single indicator of test performance
J Clin Epidemiol
(2003) - et al.
Performance of the Oraquick and Hema-Strip rapid HIV antibody detection assays by non-laboratorians
J Clin Virol
(2004) - et al.
Performance of Oraquick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants
J Clin Virol
(2009) CLIA record BP010047
(2008)- et al.
False positive rate of rapid oral fluid HIV tests increases as kits near expiration date
PLoS One
(2009) - et al.
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing
AIDS
(2006) - et al.
Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India
PLoS One
(2007) - et al.
Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India
PLoS Med
(2008) - et al.
A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status
AIDS
(2006)
Evaluation of a home-based voluntary counselling and testing intervention in rural Uganda
Health Policy Plan
Feasibility, acceptability and cost of home-based HIV testing in rural Kenya
Trop Med Int Health
Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe
AIDS Patient Care STDS
HIV self-testing and the missing linkage
PLoS Med
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
PLoS Med
Systematic reviews of diagnostic test accuracy
Ann Intern Med
Detection of human immunodeficiency virus infection in the sputum of tuberculosis patients in South India
Int J Tuberc Lung Dis
Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness
J Clin Microbiol
Acute dengue fever causes false-positive reactivity in Oraquick rapid HIV-1/2 antibody test
J Acquir Immune Defic Syndr
Oral fluid human immunodeficiency virus tests: improved access to diagnosis for infants in poorly resourced prevention of mother to child transmission programs
Pediatr Infect Dis J
Oral fluid tests for screening of human immunodeficiency virus-exposed infants
Pediatr Infect Dis J
HIV testing implementation guidance for correctional settings
Cited by (134)
HIV testing in Spain: Are we doing our job?
2021, Enfermedades Infecciosas y Microbiologia ClinicaHigh specificity of OraQuick® rapid HIV-1/2 antibody testing during dengue infection
2020, Journal of Clinical VirologyDoes antiretroviral therapy use affect the accuracy of HIV rapid diagnostic assays? Experience from a demographic health and surveillance site in rural South Africa
2020, Diagnostic Microbiology and Infectious DiseasePerformance evaluation of four point-of-care HIV tests using unprocessed specimens
2020, Journal of Clinical VirologyTracking the functional meaning of the human oral-microbiome protein-protein interactions
2020, Advances in Protein Chemistry and Structural Biology